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1. Introduction 
As shown previously [ 1,2] rat ventral prostate 
contains a large amount of prostatic binding protein 
which is secreted by this organ and plays a major role 
in the non-specific steroid binding in prostatic cytosol. 
Up until now we have studied this protein by its 
binding activity but the quantitative use of this param- 
eter was hindered by the marked effect of various 
factors (e.g. delipidation) on the binding activity. 
Here we describe the production of a monospecific 
antiserum against prostatic binding protein and its 
use in quantitative measurements by radial immuno- 
diffusion [3] . 
2. Materials and methods 
Adult male Wistar rats were used in this study. 
Cytosol of ventral prostate was prepared in Tris-HCl 
buffer (50 mM Tris, pH 7.3 at 4’C) as described in a 
previous paper [2] , to which we refer for most 
materials and methods used in this paper. [7-3H]Preg- 
nenolone (24 Ci/mmol) was obtained from New 
England Nuclear (Boston, USA). 
2.1. Measurement of pregnenolone binding 
This steroid was chosen because of its preferential 
binding to prostatic binding protein [2] . The sample 
(0.05 ml) was added to 0.25 ml of a solution of 
[3H] pregnenolone (0.1 pCi/ml) in buffer containing 
1% human serum albumin (Behringwerke, Marburg/ 
Lahn, Germany). After 3 h ofincubation at 0°C 0.2 ml 
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of a suspension of dextran-coated charcoal (4 g 
charcoal, 0.2 g dextran/lOO ml water) was added. 
The samples were incubated for 20 min at O”C, centri- 
fuged for 10 min at 0°C and the radioactivity in the 
supernatant (bound steroid) measured. 
2.2. Small scale purification of prostatic binding 
protein 
Two ml of delipidated prostatic cytosol(l2.8 mg 
protein/ml) were applied to a column (10 X 0.7 cm) 
of DEAE cellulose (Whatman DE 52) equilibrated 
with Tris buffer. The column was eluted with a linear 
O-O.3 M KC1 gradient in buffer. The absorbance at 
280 nm and pregnenolone binding activity were 
measured in all fractions (50 X 2 ml) of this column. 
The same experiment was repeated on another ahquot 
(2 ml) of dilipidated cytosol. The fractions of both 
experiments containing most of the binding activity 
were combined, concentrated on an Amicon PM-10 
membrane and applied to a Sephadex G-100 column 
(84 X 1.5 cm) which was eluted with buffer in 2.1 ml 
fractions. The fractions (37-40) containing most of 
the binding activity were combined and used for 
immunisation. 
2.3. Immunisation 
Three ml of the prostatic binding protein (Azsonm 
0.707) preparation was emulsified in 6 ml complete 
Freund’s adjuvans (Difco Laboratories). Two rabbits 
were immunised by intradermal injection of 3 ml of 
this emulsion at multiple sites [4] . Booster injections 
were given 4 weeks later. The rabbits were bled from 
an ear vein 8 weeks after the first injection and bled 
out 8 weeks later. 
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2.4. Immunochemical quantitation oj’prostatic binding 
protein by radial immunodiffusion (31 
A series of circular wells (3 mm diameter) were 
punched out from an agarose gel (10 X 10 X 0.1 cm) 
containing 1% agarose (Indubiose A 37, Industrie 
Biologique Francaise, Gennevilliers, France) and 2% 
antiserum in Tris buffer. These wells were filled with 
exactly 5 ~1 sample or standard solution. To each plate 
a set of control samples was applied, corresponding 
to dilutions of the standard preparation (see below) 
containing 0.25,0.5, 1, 1.5 and 2 arbitrary units/ml. 
The test samples were also diluted within this range. 
The diluent was 2% rat plasma in Tris buffer. After 
2 days of diffusion in a moist chamber at room tem- 
perature, the plates were washed and stained as 
described by Mancini et al. [3] _ Then the diameter 
of the circular immunoprecipitates was measured in 
two perpendicular directions under tenfold optical 
magnification. The concentration of prostatic binding 
protein was calculated using slope and intercept, 
determined by linear regression of a standard curve of 
concentration versus square diameter. 
2.5. Preparation of arbitrary standard 
A preparation of cytosol(l4.7 mg protein/ml) 
from ventral prostates of adult rats was considered 
to contain 100 arbitrary units/ml. It was diluted ten- 
fold by addition of 1 vol. rat plasma and 8 vol. buffer 
containing l”/oo sodium azide. The rat plasma, which 
does not contain prostatic binding protein itself was 
added to avoid possible losses by adsorption or prote- 
olysis. Aliquots (0.2 ml) of this diluted cytosol were 
stored at -20°C and diluted further before use. 
3. Results 
3.1. Small scale purification of prostatic binding protein 
The high concentration of prostatic binding protein 
in rat prostatic cytosol made it possible to purify this 
protein by a relatively simple technique. For this 
purpose ion exchange chromatography, on DEAE- 
cellulose was combined with gel filtration on Sephadex 
G-100 (fig.1). Delipidated cytosol [2] was used as 
starting material. In the eluate of the DEAE-cellulose 
column there was already a striking correlation of 
binding activity and protein (A,senm). This correlation 
was even more marked in the fractions from the 
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Fig.1. Purification of prostatic binding Protein. The upper- 
part of the figure shows the DEAE-cellulose chromatography 
of delipidated cytosol (see Materials and methods). The frac- 
tions containing most of the binding activity (horizontal 
bar) were analysed further by gel filtration on Sephadex 
G-100 (lower part). The top fractions of the peak of binding 
activity were combined (horizontal bar) and used for immuni- 
zation. 
Sephadex G-100 column. The fractions corresponding 
to the peak of binding activity contained only pros- 
tatic binding protein when analysed by polyacrylamide 
gel electrophoresis (5% acrylamide) in Tris-glycine 
buffer [2] and two subunits of smaller molecular 
weight (estimated M,. 14 000 and 17 000; fig.2) in 
SDS-containing gels, according to Weber and Osborn 
[5]. The top fractions (37-40) of this peak were 
combined and used for immunisatipn. 
3.2. Production of antisera against prostatic binding 
protein 
Both rabbits responded to immunisation by the 
formation of antibodies. The specificity of these anti- 
sera was checked by the double immunodiffusion 
technique of Ouchterlony [6] and by crossed 
immunoelectrophoresis [7] . Purified prostatic binding 
protein or total prostatic cytosol formed a single 
immunoprecipitation line with these antisera by the 
Ouchterlony technique (fig.3(A)). These precipitation 
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Fig.2. Polyacrylamide gel electrophoresis in SDS-containing gels. The method of Weber and Osborn [S] was followed using 10% 
acrylamide and 0.1% SDS in phosphate buffer. The samples consisted of 25 ~1 total prostatic cytosol (a) or purified prostatic 
binding protein (b) diluted, respectively, twenty-fold and four-fold with sample buffer, containing no mercaptoethanol. The 
arrow shows the position of cytochrome c. 
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Fig.3. (A) Double immunodiffusion pattern according to Ouchterlony [6] well 1 contains 10 r.d antiserum; well 3,s ~1 of 
total prostatic cytosol (dilution 1:20), wells 2 and 4,s ~1 of a solution of purified prostatic binding protein. (B) Crossed 
immunoelectrophoresis [7]. The sample (5 ~1 of twenty-fold diluted prostatic cytosol) was run first for 3 h at 100 V in a 2% 
agarose gel containing no antiserum and thereafter for 20 h at 40 V in a perpendicular direction in a gel containing 1.5% antiserum. 
The buffer in this experiment consisted of sodiumdiethylbarbiturate (43 mM), sodium acetate (43 mM) and HCl to pH 8.2. 
(C) Single radial immunodiffusion, corresponding to the points of the standard curve. 
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lines showed complete fusion as expected for immuno- 
logical identity. Both subunits prepared by polyacryl- 
amide gel electrophoresis in SDS-containing gels also 
produced similar immunoprecipitation lines. 
In crossed immunoelectrophoresis [7] prostatic 
cytosol contained a large peak of immunologically 
reacting material, preceded by a much smaller one 
with higher electrophoretic mobility (fig.3(B)). The 
complete fusion of the precipitation lines of both 
peaks indicates that they correspond to immuno- 
logically closely related forms. Additional evidence 
of the specificity of the antiserum forms the pre- 
cipitation of 60.9% of [3H]pregnenolone bound in 
diluted delipidated prostatic cytosol (protein: 
1 .l mg/ml) by incubation for 30 min at 0°C with 
2 vol. antiserum. Finally, the antiserum gave no 
reaction with rat serum or cytosol prepared from rat 
kidney, lung, liver, thymus, testes, epididymes and 
uterus. 
3.3. Quantitative estimation of prostatic binding 
protein by radial immunodiffusion 
After incubation the antigen in test or control 
samples formed clearcut circular immunoprecipi- 
tates in the antibody-containing agarose gels (fig.3(C)). 
A very good linear correlation existed between the 
amount of antigen and the square diameter of these 
circles with correlation coefficients for the standard 
curve better than 0.999. The coefficient of variation 
for 20 samples measured in duplicate was 4.8%. 
Finally, the sensitivity of the assay posed no problem, 
since the samples usually had to be diluted IO-200 
fold. The results of this assay are expressed in arbi- 
trary units, since there was not enough purified 
prostatic binding protein for calibration on the basis 
of weight. For purified prostatic binding protein, 
prepared as described above, a concentration of 
1 unit/ml corresponds to an A 280 nm of 0.036 and a 
protein concentration of 0.044 mg/ml in the Lowry 
method [8] using human serum albumin as reference. 
In prostatic cytosol of 6 months old male rats the 
concentration of prostatic binding protein was 
11 SO + 2.04 (n = 4) units/mg protein. When we use 
the conversion factor of 0.044, this corresponds to 
50.6% of the total protein in prostatic cytosol, 
measured by the Lowry method. This estimate is 
higher than the estimate of 15-20% obtained on the 
basis of steroid binding [2] . This may indicate that a 
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part of prostatic binding protein shows no binding 
activity even in delipidated cytosol. The estimate of 
50%, on the other hand, is compatible with the relative 
intensity of the corresponding protein bands in SDS- 
polyacrylamide gel electrophoresis. 
3.4. Exfects of various factors on the concentration of 
prostatic binding protein 
As shown previously [2] , the binding of steroids 
of prostatic binding protein increases several times by 
delipidation, whereas incubation with dithiothreitol 
at 37°C results in an almost complete loss of binding 
activity. These factors had only a small effect on the 
immunochemically measured concentration of pros- 
tatic binding protein. Indeed, after delipidation or 
treatment with dithiothreitol, these values were, 
respectively, 108.9% and 92.3% of the control value. 
4. Discussion 
In this paper we describe a small scale purification 
of prostatic binding protein and the production of a 
monospecific antiserum against it. This antiserum was 
used for the quantitative measurement of prostatic 
binding protein by the method of radial immuno- 
diffusion [3] . This technique is more specific and 
more reliable than the measurement of binding. 
Indeed, various factors which enhance (delipidation) 
or destroy (reducing reagents, low pH) the binding 
activity have little or no effect on the immunochemically 
determined concentration. Furthermore, the 
immunochemical measurement is easier to perform 
and requires only a very small sample. By use of this 
method, we could confirm that prostatic binding 
protein is a major constituent of prostatic cytosol 
and specific for this organ. We hope to use this tech- 
nique for a more detailed study of‘prostatic binding 
protein as a function of age and hormonal treatment 
and for the further characterization of this protein. 
Finally, the antiserum will allow us to perform some 
other experiments on the localization and productior 
of prostatic binding protein. 
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